Norgestimate And Ethinyl Estradiol
Product Images NDC 68788-7894

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68788-7894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A forest plot titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' comparing effect estimates of breast cancer risk for Ever COC vs. Never COC use and Current COC use vs. Never-Use. It includes studies from 2002 to 2017 with odds ratios (OR), risk ratios (RR), and hazard ratios (HR) and corresponding confidence intervals plotted on an effect estimate scale from -1.5 to 2.0.*

FDA Label Image

Chemstructures (Chemstructures)

Chemical structures of Norgestimate and Ethinyl Estradiol, the active ingredients in the product Norgestimate and Ethinyl Estradiol by Preferred Pharmaceuticals Inc. The structures are labeled with their USP names.*

FDA Label Image

Logo (Logo)

FDA Label Image

Img3 (Img3)

A vertical chart illustrating pregnancy rates per 100 women in one year associated with various birth control methods. The chart shows fewer pregnancies at the top with methods like implants, injections, intrauterine devices, and sterilization; followed by birth control pills, skin patch, and vaginal ring with hormones. Moderate pregnancies correspond to condoms and diaphragm, then no sex during fertile days, spermicide, and withdrawal. Most pregnancies occur with no birth control at the bottom.*

FDA Label Image

Figurea (Figurea)

A dosing blister card for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg / 0.035 mg showing a 28-day cycle with four weeks of pills. The first three weeks contain blue pills labeled as active, and the fourth week contains light green pills labeled as inactive. The card includes arrows indicating the start of each week and a note about keeping medication out of reach of children.*

FDA Label Image

Figureb (Figureb)

An instructional diagram for Norgestimate and Ethinyl Estradiol Tablets USP depicting a 28-day pill pack schedule divided into four rows for Weeks 1 to 4, with circles indicating daily pills from Sunday to Saturday. The diagram differentiates pill colors and activity: white to off-white, light blue, and blue pills are active, while light green pills are inactive.*

FDA Label Image

Figurec.jpg (Figurec)

An instructional diagram labeled Figure C, showing a hand holding a circular tablet or pill near two empty circles marked for Sunday and Monday. The image includes arrows indicating 'Start' and 'Week 2' pointing to the circles, suggesting guidance on a weekly dosing schedule.*

FDA Label Image

Figured (Figured)

Illustration showing two blister pack diagrams for Norgestimate and Ethinyl Estradiol tablets. Each pack displays a 4-week supply labeled with days of the week for tracking tablet use. A hand is shown peeling back the blister foil over the Saturday tablet. Each panel includes dosage strengths and a child safety warning.*

FDA Label Image

Figuree (Figuree)

An instructional illustration showing a hand pointing to a pill pack labeled with days of the week (Sunday and Monday) and the words "Start" and "Week 2" to guide the user in taking the medication Norgestimate and Ethinyl Estradiol by Preferred Pharmaceuticals Inc.*

FDA Label Image

Figuref (Figuref)

An instructional diagram displaying a 4-week weekly pill schedule for Norgestimate and Ethinyl Estradiol. Each week has two circle placeholders labeled for days Sunday and Monday. A hand with a fingernail presses the circle for Sunday in Week 4, indicating pill placement or selection to start the cycle.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Trinessa (norgestimate And Ethinyl Estradiol Tablets (Trinessa (norgestimate And Ethinyl Estradiol Tablets)

The packaging label for TriNessa (norgestimate and ethinyl estradiol tablets) indicates it is a generic for Ortho Tri-Cyclen 28 Day. The label includes directions in English and Spanish to use as directed by the doctor. It shows manufacturer details of Glenmark Pharmaceuticals Inc., USA, and storage directions. The label also displays a barcode and a QR code, with cautionary statements about prescription transfer restrictions and medication storage temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.